← FDA ENFORCEMENT
D-0626-2024Class I

MAIN PRODUCTS INC

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
MAIN PRODUCTS INC
Product type
Drug
Status
Ongoing
Report date
2024-08-14
Distribution
Nationwide within the U.S
Firm state
CA
Product quantity
57, 340 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall

Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Product description

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

Code / lot info

All lots within expiry

Other recalls SPEQ maps to Documentation & Change Control
See all Documentation & Change Control recalls →

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →